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I N T R O D U C T I O N
Anthrax toxin is composed of three proteins: edema 
factor (EF; 89 kD), lethal factor (LF; 90 kD), and pro-
tective antigen (PA; 83 kD). The former two are en-
zymes that, to carry out their functions, must gain access 
to the cytosol of targeted cells. This they achieve through 
the agency of the third component, PA. The sequence 
of events by which this occurs is the following (for a gen-
eral  review  of  anthrax  toxin,  see  Young  and  Collier, 
2007). (a) PA binds to a receptor on the cell surface, 
where it is cleaved by a protease into a 20-kD (PA20) and 
a 63-kD (PA63) fragment. (b) The latter, which remains 
bound to the cell surface, oligomerizes to form ring-
shaped  heptamers  (Lacy  et  al.,  2004)  and  octamers 
(Kintzer et al., 2009), collectively termed the prepores, 
and in so doing creates binding sites for EF and LF. 
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(c) With up to three (for the heptamer) (Melnyk et al., 
2006) or four (for the octamer) (Feld et al., 2010) of 
these sites occupied by EF and/or LF, the complexes 
undergo receptor-mediated endocytosis and ultimately 
arrive in an acidic vesicle compartment. (d) There the 
prepore undergoes a conformational change, resulting 
in its forming a pore (which we shall refer to as a chan-
nel) in the endosomal membrane that serves as the con-
duit for the translocation of EF and LF to the cytosol.
The (PA63)7 channel is a mushroom-shaped structure 
with a cap, containing the binding sites for EF and LF 
and a long 100-Å stem (Katayama et al., 2008) (Fig. 1). 
When reconstituted into a planar phospholipid bilayer, 
the (PA63)7 channel has a conductance of 55 pS (in 
100 mM KCl, pH 5.5), is highly (although not ideally) 
permeable to univalent cations, and under appropriate 
voltage and pH conditions translocates EF and LF across 
the membrane (Krantz et al., 2006). The diameter of 
the 100 Å–long stem is 15 Å (Nguyen, 2004), whereas 
the diameters of EF and LF, even in the molten globular 
state they assume at pH 5.5 (Krantz et al., 2004), are 
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Anthrax toxin consists of three proteins: lethal factor (LF), edema factor (EF), and protective antigen (PA). This 
last forms a heptameric channel, (PA63)7, in the host cell’s endosomal membrane, allowing the former two (which 
are enzymes) to be translocated into the cytosol. (PA63)7 incorporated into planar bilayer membranes forms a chan-
nel that translocates LF and EF, with the N terminus leading the way. The channel is mushroom-shaped with a cap 
containing the binding sites for EF and LF, and an 100 Å–long, 15 Å–wide stem. For proteins to pass through the 
stem they clearly must unfold, but is secondary structure preserved? To answer this question, we developed a 
method of trapping the polypeptide chain of a translocating protein within the channel and determined the mini-
mum number of residues that could traverse it. We attached a biotin to the N terminus of LFN (the 263-residue 
N-terminal portion of LF) and a molecular stopper elsewhere. If the distance from the N terminus to the stopper was 
long enough to traverse the channel, streptavidin added to the trans side bound the N-terminal biotin, trapping 
the protein within the channel; if this distance was not long enough, streptavidin did not bind the N-terminal bio-
tin and the protein was not trapped. The trapping rate was dependent on the driving force (voltage), the length of 
time it was applied, and the number of residues between the N terminus and the stopper. By varying the position 
of the stopper, we determined the minimum number of residues required to span the channel. We conclude that 
LFN adopts an extended-chain configuration as it translocates; i.e., the channel unfolds the secondary structure of 
the protein. We also show that the channel not only can translocate LFN in the normal direction but also can, at 
least partially, translocate LFN in the opposite direction.
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the channel, unblocking of the channel at negative volt-
ages would be unaffected by the trans streptavidin. By 
varying the position of x, we would thereby find a cutoff 
position, p, where for x > p, residue 1 can reach the 
trans side, and for x < p, it cannot. To implement this 
strategy, we used two different types of stoppers, which 
we now describe.
Yellow fluorescent protein (YFP). The 27-kD Venus YFP was 
appended as a stopper to the C terminus of truncated 
LFN constructs of various lengths, and a biotin was at-
tached at the N terminus (Fig. 2 B). Experiments were 
then performed as described above in General strategy, 
and a cutoff position p was determined (see Results), as 
described there. There are two problems with this ap-
proach that make the meaning of the so-determined 
cutoff position ambiguous. First, because the size of the 
vestibule leading up to the stem of the (PA63)7 channel 
(Fig. 1) is not known precisely, it is not clear where this 
stopper “stops” and hence what length is actually being 
measured. In the two extremes, YFP either could be 
stopped from entering the vestibule at all, or it could be 
stopped only when it reaches the beginning of the stem. 
Second, even if we knew where the YFP was stopped, it 
turns out that the forces we are applying with our posi-
tive voltage pulses could partially unfold it in the region 
where it is attached to the C terminus of LFN (see Dis-
cussion); hence, an unknown number of its residues 
could enter the stem. Thus, the actual length of peptide 
chain in the stem would be longer than that indicated 
by the cutoff position p. Because of these uncertainties, 
we resorted to a different stopper described below.
Biotin at positions other than the N terminus. Even though 
LFN with a biotin attached to its N terminus is readily 
translocated through the (PA63)7 channel, a biotin at-
tached at most other positions in LFN severely retards its 
translocation; with two successive biotins attached, LFN 
much larger. Thus, in order for these proteins to pass 
through the stem, they must unfold, but it is not known 
to what extent this occurs. Certainly, tertiary structure 
must be lost, but given that the stem is wide enough to 
accommodate an  helix with its side chains, it is not 
clear to what extent secondary structure is preserved. 
In this paper, we address this issue and report data sug-
gesting that the polypeptide chain can adopt a fully 
extended conformation as it translocates through the 
channel’s stem.
Rationale and design of experiments
General strategy. With the transmembrane voltage held 
at +20 mV (cis voltage relative to that of the trans), LFN 
(the 263-residue N-terminal end of LF) added to the cis 
solution enters the (PA63)7 channel N-terminal end first 
and blocks it (Zhang et al., 2004a). If the voltage is then 
stepped to a larger cis-positive value (≥+40 mV), LFN is 
translocated across the membrane through the channel 
to the trans solution, whereas if the voltage is stepped to 
a cis-negative value, LFN exits the channel back to the 
cis solution, thereby unblocking it (Zhang et al., 2004b). 
Our general strategy to determine the number of LFN 
residues required to span the length of the channel was 
as follows. We attached a biotin at position 1 and a mo-
lecular stopper, which prevents further translocation of 
LFN, at position x. After blocking the channel with this 
construct at +20 mV, and confirming that after the volt-
age was stepped to +50 or 55 mV the channel was un-
blocked when the voltage was stepped back to a negative 
value, we would then add streptavidin to the trans solu-
tion. If the distance from 1 to x was long enough to trav-
erse the channel, streptavidin would tightly bind the 
biotin at position 1, and consequently unblocking of 
the channel at negative voltages would be prevented. 
(An idealized current record before and after streptavi-
din addition is shown in Fig. 2 A.) If, on the other hand, 
the distance from 1 to x was not long enough to traverse 
Figure 1.  Structure of the (PA63)7 channel.   
Model  (Nguyen,  2004)  of  the  (PA63)7 
channel (left) and its structure (Katayama   
et al., 2008) as obtained from negative-stain 
electron  microscopy  at  25-Å  resolution 
(right). The parallel dashed lines indicate 
the thickness of the hydrophobic interior 
of the phospholipid bilayer. The red arrow 
marks the likely position of the -clamp.  Basilio et al. 345
A plasmid containing a version of Venus YFP was provided by 
D. Reeves (ARMGO Pharma, Tarrytown, NY). The gene for Venus 
YFP with BamHI ends was amplified by PCR, digested with BamHI, 
and ligated to the BamHI-digested pDBS15 to create pDBS18. 
pDBS18 thus encodes a 603-residue protein (LFN-YFP) with LFN 
residues 1–263, followed by glycine-serine-glycine, followed by Venus 
YFP, all with the pET15b-encoded thrombin-cleavable His6-tag 
sequence (Merck) at its N terminus.
LFN1C-YFP was created by site-directed mutagenesis reactions, 
using the QuikChange Site-Directed Mutagenesis kit on pDBS18. 
To delete central portions of LFN1C-YFP, complementary muta-
genic oligonucleotides were used, with sequences upstream and 
downstream of those encoding residues subject to deletion, and in-
cluding the linker residues. Those oligonucleotides were used to 
delete residues from pDBS18, using the QuikChange Site-Directed 
Mutagenesis kit, resulting in the various LFN products: 1–23, 1–33, 
1–43, 1–83, and 1–133, all with the YFP attached at the C terminus 
and the His6 tag attached at the N terminus. All the LFN cysteine 
mutants were created by the QuikChange Site-Directed Mutagene-
sis kit and contained the same His6 tag at the N terminus.
Wild-type PA (83 kD), PA R178A/K214E, LFN, and LFN-YFP 
(residues 1–263 of LF, containing the N-terminal His6 tag) were 
translocation  is  essentially  completely  prevented  (see 
Results). Moreover, we have good evidence that the po-
sition at which biotin is stopped is at the so-called   
-clamp (Krantz et al., 2005) that lies near the entrance 
to the stem (see Results). Constructs were made of whole 
LFN, with biotins attached either to residue x or to resi-
dues x and x + 1, and also with a biotin at its N terminus 
(Fig. 2 B). The cutoff position p was then determined 
by experiments as described above in General strategy 
(see Results).
M AT E R I A L S   A N D   M E T H O D S
Molecular biology and protein purification
A protein with Venus YFP fused, in frame, at the C terminus of 
LFN was made as follows. pDBS15 was created by mutating the 
stop codon of LFN to a serine codon in the plasmid pET15b-LFN 
(Lacy et al., 2002), using the QuikChange Site-Directed Mutagen-
esis kit (Agilent Technologies), and was then digested with BamHI. 
Figure 2.  Blocking of (PA63)7 channels by LFN (with a biotin at position 1 and a molecular stopper at position x) at positive voltages and 
unblocking at negative voltages. (A) Idealized current record. There is no gating of the channels before LFN addition to the cis solution. 
After addition, the channels are blocked by positive voltage pulses and become completely unblocked at negative voltage pulses. After 
the subsequent addition to the trans solution of streptavidin, which was able to bind the biotin at position 1, unblocking at negative 
voltages is no longer complete and diminishes over time. The dashed line is the zero current level. (B) Cartoons of LFN constructs with 
a biotin at position 1 and either a YFP stopper (left) or a double-biotin stopper (right). LFN is depicted as a wavy gray line, biotins are in 
orange, the N-terminal (His)6 tag is in blue, and YFP is depicted as a yellow  barrel. The green line indicates the distance from the stop-
per to the biotin at position 1. Note that the double-biotin stopper is attached at various positions on full-length LFN. In contrast, the YFP 
stopper is at the C-terminal end of various LFNs, whose C-terminal ends have been truncated.346 Trapping a permeating LFN in the anthrax channel
of 1 ml containing symmetric buffered solutions of 100 mM KCl, 
5 mM potassium succinate, and 1 mM EDTA, pH 5.5, which could 
be stirred by small magnetic bars. Agar salt bridges (3 M KCl, 3% 
agar) linked Ag/AgCl electrodes in saturated KCl baths to the cis 
and trans compartments. The membrane-forming solution was 
3% diphytanoyl-phosphatidylcholine (Avanti Polar Lipids, Inc.) 
in n-decane, and membrane formation was monitored both visu-
ally and by capacitance (500 pF). All experiments were done 
under voltage clamp conditions with a Bilayer Clamp (BC-535C; 
Warner Instruments); voltages are those of the cis solution (to 
which protein was added) with respect to the trans solution, which 
was held at virtual ground. Current responses were filtered at   
3 kHz by a low-pass eight-pole Bessel filter (Warner Instruments), 
recorded by computer via an analogue-to-digital converter (NI 
USB-6211; National Instruments) at 20 Hz using IGOR NIDAQ 
Tools MX 1.0 and IGOR 6.0.3.1 (WaveMetrics), and recorded by 
a DMP-4B Physiograph chart recorder (Narco Bio-Systems, Inc.) 
for annotation purposes.
(PA63)7 channel formation and (His)6-LFN conductance block
After membrane formation, PA63 prepore heptamer was added   
to the cis compartment (to a final concentration of 1 µg/ml   
[2 nM]), which was held at a  of +20 mV with respect to the 
trans compartment. When the conductance resulting from (PA63)7 
channel formation reached an appropriate level (generally after 
30 s), the cis compartment was perfused, which removed the 
(PA63)7 from solution and caused the conductance to level off. 
Perfusion was accomplished using a BPS-2 Bilayer Perfusion Sys-
tem (Warner Instruments) coupled to a pair of syringes; 10 vol 
were exchanged in 3 min. LFN or one of its constructs was then 
added to the cis compartment (final concentration of 120 nM). 
The progress of LFN binding to (PA63)7 channels and blocking 
them was monitored by the continuous fall of conductance.
Translocation experiments
After LFN conductance block of (PA63)7 channels was complete, 
excess LFN was removed from the cis compartment by perfusion, 
while  was held constant at +20 mV. After this,  was stepped 
to a larger voltage (e.g., +50 mV), and the rate of LFN transloca-
tion was determined, as reflected in the rate of conductance rise 
caused by LFN traversing the channel and exiting into the trans 
solution. In general, the final conductance was ≥90% of the con-
ductance before blocking by LFN.
For the N-terminal biotin-reacted LFN 1–263 constructs con-
taining a stopper, after the normally translocating positive voltage 
was applied for 60 s, and little or no translocation was observed, 
we repeatedly stepped the voltage for 60 s to a negative voltage, 
and then back to +20 mV, to confirm that these channels were 
blocked and had not simply disappeared. Negative voltages drive 
LFN out of the channel back to the cis side, so that the conduc-
tance immediately obtained at +20 mV (before the slow reblocking 
of the channels by still-attached LFN) represents that of unblocked 
channels. The conductance ultimately obtained was ≥90% of the 
conductance level before blocking by LFN.
Streptavidin binding experiments
After LFN block of (PA63)7 channels was complete at +20 mV, the 
pulsing protocol began with a negative voltage step, in which we 
monitored the unblocking of the LFN, followed by a positive volt-
age step, in which the LFN reblocking was observed. This was 
repeated several times to obtain a stable “baseline” value of unblock-
ing. After this level was attained, we proceeded to add streptavidin 
to the trans compartment to a final concentration of 50 µg/ml   
(1 µM) while maintaining the pulsing protocol. We then observed 
whether or not the baseline of unblocking was reduced after the 
streptavidin addition, indicating that the N-terminal biotin in LFN 
had or had not been grabbed.
expressed  recombinantly  and  purified  as  described  previously 
(Krantz et al., 2004, 2005; Pimental et al., 2004; Zhang et al., 
2004b). We inferred from the fact that the purified LFN-YFP is 
bright yellow that the YFP moiety is correctly folded in these con-
structs. The heptameric prepore form of PA63 was prepared by 
nicking PA83 with trypsin and purifying the PA63 heptamer from 
the smaller 20-kD fragment using anion-exchange chromatogra-
phy (Cunningham et al., 2002).
Biotinylation of (His)6-LFN mutants
The LFN cysteine mutants were reduced with 20 mM dithiothrei-
tol and then dialyzed into degassed 150 mM NaCl and 20 mM 
Tris, pH 8.5. 100 µl of a given LFN mutant (2 mg/ml) was incubated 
with 3 µl N-biotinylaminoethyl methanethiosulfonate (MTS-biotin; 
20 µg/µl; Toronto Research Chemicals) for 30 min at room 
temperature. (N-[6-(biotinamido)hexyl]-3-(2-pyridyldithio)propio-
namide [HPDP-biotin] labeling, which was done only for the experi-
ment shown in Fig. S1 B, was similar to that of MTS-biotin, except 
that the incubation was done for 3 h at 30°C; Qiu et al., 1996.) 
The reaction was stopped by dialyzing out the biotinylating reagent 
at 4°C. To confirm that virtually all of the protein was labeled, biotin-
reacted and unreacted protein were incubated with streptavidin. 
The biotin-reacted LFN exhibited a shift on the gel, whereas the 
unreacted protein was unaffected (Fig. 3); wild-type LFN, which 
has no native cysteines, was also unaffected (not depicted).
Planar lipid bilayers
Bilayers  were  formed  by  the  brush  technique  (Mueller  et  al., 
1963) across a 250-µm diameter aperture in a polystyrene cup 
(Wonderlin et al., 1990). Membranes separated two compartments 
Figure 3.  Example of an SDS nonreducing 15% polyacrylamide 
gel of an LFN mutant with cysteines at residues 1 and 126. Lane 
1, streptavidin; lane 2, the LFN mutant reacted with MTS-biotin, 
incubated with streptavidin, and then subsequently treated with 
dithiothreitol (DTT); lane 3, the LFN mutant reacted with MTS-
biotin; lane 4, the LFN mutant reacted with MTS-biotin and then 
incubated with streptavidin. Note the gel shift in lane 4 caused by 
the incubation with streptavidin. In the cartoons above each lane, 
the four green balls represent tetrameric streptavidin and the or-
ange rings and tail represent biotin; only one of the two biotins 
(one at residue 1 and one at residue 126) that were introduced by 
the reaction of LFN mutant with MTS-biotin is depicted.  Basilio et al. 347
negative voltages of LFN-treated membranes. Something 
approaching the idealized record in Fig. 2 A is achieved 
when the (PA63)7 gating is slow (Fig. 4 A). In most cases, 
the full unblocking of LFN at negative voltages is ob-
scured by the concurrent intrinsic closing of the chan-
nels at those voltages (Fig. 4 B). We routinely checked 
the gating behavior of a (PA63)7-treated membrane be-
fore adding LFN, and on that basis we chose the lengths 
of times we held the voltage at positive and negative po-
tentials. This was strictly an aesthetic decision; it did not 
affect the main conclusion drawn from an experiment, 
namely, whether trans streptavidin did or did not grab 
the N-terminal biotin in LFN.
YFP as the stopper
After establishing, as expected, that YFP attached to the 
C terminus of LFN prevented translocation (Fig. 5), we 
proceeded  to  test  truncated  LFN  constructs  to  deter-
mine if the N terminus reached the trans solution.   
A representative example is shown in Fig. 6. It is clear that 
trans streptavidin grabbed the N-terminal biotin of LFN 
that had been truncated to 83 residues. The results of 
these experiments are summarized in Fig. 7, where we 
see that 23 residues are insufficient to traverse the chan-
nel, whereas 33 residues or more are sufficient. The cut-
off appears to be close to 33 residues (see Fig. 7).
A confirmation that the reason that trans streptavidin 
prevented unblocking of the channels at negative volt-
ages, as seen in Fig. 6, was because it bound the N-terminal 
biotin would be to show that an excess of free biotin 
Online supplemental material
Fig. S1 describes two control experiments that confirm that 
the trans action of streptavidin is indeed the binding of the 
N-terminal biotin in the LFN construct 1–83 YFP: (1) stopping 
the reaction with an excess of free biotin, and (2) reversing the 
reaction with the addition of TCEP that reduces the S–S bond 
between the cysteine at position 1 in LFN and the HPDP-biotin. 
Fig. S1 is available at http://www.jgp.org/cgi/content/full/jgp 
.201010578/DC1.
R E S U LT S
Intrinsic gating of (PA63)7 channels
Before presenting our data on the trapping of LFN con-
structs within the (PA63)7 channel, we first consider the 
voltage-gating behavior of these channels. By doing so, 
we hope the reader will more clearly understand the re-
cords shown in the following sections. As has been re-
ported, (PA63)7 channels tend to “turn off” at both positive 
and negative voltages, with the degree and rapidity of 
turn off much greater at negative voltages (Blaustein   
et al., 1989; Anderson and Blaustein, 2008). We see illus-
trations of this in Fig. 4. The mechanism of this voltage 
gating is not understood, although an interesting study 
has recently been made of the gating at negative volt-
ages (Anderson and Blaustein, 2008). Moreover, the 
magnitude  of  the  gating  varies  unpredictably  from 
membrane  to  membrane;  thus,  in  some  membranes 
modest slow turn off occurs at 60 mV, whereas in oth-
ers rapid and almost complete turn off occurs at 20 mV. 
This turn off complicates the kinetics of unblocking at 
Figure 4.  Records illustrating 
the  voltage  gating  of  (PA63)7 
channels  and  its  effect  on  the 
LFN unblocking kinetics. Before 
(His)6-LFN  addition  to  the  cis 
solution, there is some gating of 
the channels at positive voltage 
pulses and very significant gating 
at negative voltage pulses; the lat-
ter is more marked in B than in A.   
The  gating  kinetics  are  such 
that channels that have closed at 
negative voltages rapidly reopen 
at positive voltages. After LFN ad-
dition (arrow), blocking occurs 
at positive voltage pulses, but the 
unblocking  kinetics  at  negative 
voltage  pulses  are  convoluted 
with the intrinsic gating kinetics 
of the channels. In A, actual un-
blocking at negative voltage can be seen. In B, unblocking at negative voltage pulses is totally obscured by the intrinsic gating kinetics 
of the channels. Nevertheless, the fact that unblocking has occurred at negative voltages is revealed when the voltages are stepped back 
to positive values. Note that in both A and B, complete unblocking has not occurred during the negative voltage pulses, as the initial 
current when the voltage is stepped back to positive values is smaller than the current before LFN addition. The dashed line in A and   
B marks the zero current level. Before the start of each record, (PA63)7 was added to the cis compartment to a concentration of 2 nM, with 
the voltage held at +20 mV, and after an appropriate level of current was reached, the cis compartment was perfused, which removed 
free (PA63)7 from the solution and caused the current to level off. The voltage protocol of +45 and 50 mV was then begun. At the ar-
rows, the (His)6-LFN construct 1–83, with YFP attached to the C terminus and biotin attached at residue 1, was added to a concentration 
of 120 nM.348 Trapping a permeating LFN in the anthrax channel
given pulse length (5 s), the rate of streptavidin grab-
bing increases about e-fold per 5.5 mV (Fig. 8 A), and 
that for a given voltage (+40 mV), the rate increases 
about e-fold per 8-s pulse duration (Fig. 8 B). It is intui-
tively obvious why the rate of streptavidin binding to the 
N-terminal biotin should increase with voltage and pulse 
duration, as both of these factors contribute to the length 
of time that the N-terminal biotin was exposed to the 
trans solution. Why the rate should increase with the 
length of the LFN construct (Fig. 7), although not so 
obvious, has a ready explanation. Namely, as a result of 
Brownian motion of the peptide chain, the N terminus 
must fluctuate between the times it is exposed to the trans 
solution and the times it has withdrawn into the channel. 
The longer the length of the constructs, the longer the 
fraction of time that the N-terminal residue spends 
exposed to the trans solution.
Biotin as the stopper
The introduction of a biotin at most positions in LFN (the 
N terminus excepted), or at two successive positions, vir-
tually completely stopped LFN translocation through the 
stopped the reaction and/or that unblocking was re-
stored when the biotin, with its attached streptavidin, 
was removed from the N terminus by the disulfide-reduc-
ing agent tris-(2-carboxyethyl)phosphine (TCEP). We were 
successful in demonstrating the former (Fig. S1A), but we 
were initially unsuccessful in demonstrating the latter. 
The reason for this, we felt, was that the disulfide linker 
of MTS that attaches the biotin to the N terminus of 
LFN is so short that the disulfide bond is buried in the 
streptavidin-binding pocket and is thereby made inac-
cessible to TCEP (Fig. S1 B, inset). That this was indeed 
the explanation was shown when we attached the biotin 
with the longer linker HPDP-biotin. In this case, un-
blocking was rapidly restored by the trans addition of 
TCEP (Fig. S1 B).
The  kinetics  of  trans  streptavidin  engaging  the   
N-terminal biotin are a function of both the magni-
tude of the voltage pulse driving the LFN chain through 
the (PA63)7 channel and the length of that pulse. The 
larger the magnitude of the pulse and the longer its du-
ration, the faster the kinetics. Taking again the 83-residue 
truncated construct as representative, we see that for a 
Figure 5.  Demonstration that YFP attached to the C terminus of LFN prevents its translocation. (A) Before the start of the records, the 
(PA63)7-induced conductance had leveled off, (His)6-LFN or (His)6-LFN-YFP had been added to the cis compartment to a concentration 
of 120 nM, the conductance had fallen to a fraction of the value before LFN addition, and LFN had been perfused out of the cis compart-
ment. At t = 0, the voltage was stepped from +20 to +50 mV. We see that LFN was readily translocated, with a halftime of 10 s, whereas 
no translocation at all of LFN-YFP had occurred after more than 60 s. The conductance is normalized to the value before the addition of 
LFN or LFN-YFP. (B) The LFN-YFP record in A is a blow-up of the boxed segment of this record. The point of the rest of the record is to 
show that the (PA63)7 channels are still present and have not simply disappeared. The 80-mV pulses drive LFN out of the channel back 
to the cis side. The initial conductance when the voltage is stepped backed to +20 mV is a result of the channels that were unblocked at 
80 mV; the subsequent slow fall in conductance is caused by LFN still attached to those channels. The dashed blue lines mark the con-
ductance before and after LFN-YFP block. We see that after five 80-mV pulses, the conductance has reached the value before LFN-YFP 
addition, thus confirming that (PA63)7 channels have not disappeared. The black dashed line is the zero current level.  Basilio et al. 349
firmed in a separate experiment for each biotinylated 
LFN that it was not translocated (e.g., as in Fig. 9).
Before presenting the results of these experiments, 
we wish to make a point concerning a difference in 
methodology between these experiments with biotin as 
the stopper and those previously described with YFP as 
the stopper. With the exception of LFN 1–263, all the 
experiments with the YFP stopper, as depicted in Fig. 7, 
were done on wild-type (PA63)7 channels, whereas all the 
experiments  to  be  described  with  the  biotin  stopper 
were done on the double-mutant (PA63)7 channel R178A/
K214E. Why was this? Because none of our truncated 
LFN mutants contained the region that binds to (PA63)7 
in the mushroom cap (Melnyk et al., 2006), unblocking 
at  negative  voltages  was  fairly  rapid.  In  contrast,  un-
blocking at negative voltages of whole LFN, which con-
tains the region that binds to (PA63)7, was extremely 
slow  (unpublished  data).  (This  is  probably  mainly  a 
(PA63)7 channel (Fig. 9). A priori we suspected that the 
biotins were stopped at the -clamp (which is near the 
entrance to the stem of the channel) for the following 
reasons. When the phenylalanines of the -clamp were 
mutated to alanines, the single-channel conductance 
doubled (Krantz et al., 2005), suggesting that a restric-
tion in channel diameter occurs at the -clamp that 
could impede the passage of biotin past it. In addition, 
the -clamp was identified as the binding site for hydro-
phobic groups (Krantz et al., 2005), which suggests that 
it could hinder biotin movement by binding it. That the 
biotins were indeed stopped at the -clamp was con-
firmed by the observation that when the phenylalanines 
of the -clamp were mutated to alanines, LFNs with intro-
duced biotins were readily translocated (Fig. 9). With this 
established, we proceeded to test whole LFNs with biotins 
introduced at various positions to determine if the   
N-terminal biotin reached the trans solution. We con-
Figure 6.  Example of a truncated 
(His)6-LFN  construct  (LFN  1–83), 
whose N terminus reached the trans 
solution. Before the start of the re-
cord, (PA63)7 was added to the cis 
compartment  to  a  concentration 
of 2 nM, with the voltage held at 
+20 mV; after an appropriate level 
of  current  was  reached,  the  cis 
compartment  was  perfused,  which 
removed the (PA63)7 from the solu-
tion and caused the current to level 
off. The voltage protocol of + 80 mV 
for 5 s and 40 mV for 15 s was then 
instituted. At the first arrow, the LFN 
construct 1–83, with YFP attached to 
the C terminus and biotin attached 
at residue 1, was added to the cis so-
lution to a concentration of 120 nM,   
and a constant level of unblocking 
was obtained. At the second arrow, 
streptavidin was added to the trans 
compartment to a concentration of 
1 µM. We see a dramatic decrease of 
unblocking over time, thus demon-
strating that the biotin at residue 1   
had reached the trans solution and 
had been grabbed by streptavidin, 
thereby  preventing  those  chan-
nels from becoming unblocked at 
40 mV. The dashed line is the zero   
current  level.  In  the  cartoon,  YFP 
is  depicted  as  a    barrel  (Rekas 
et  al.,  2002),  biotin  is  in  orange, 
the N-terminal (His)6 tag is in blue, 
streptavidin is represented by four 
green balls, and the (PA63)7 chan-
nel is depicted in black with a wide 
opening to the cis solution and the 
entrance  to  the  long  stem  of  the 
channel  marked  by  the  -clamp. 
The ambiguity of where YFP is stopped is depicted by two extremes: in the first, it cannot enter the channel at all, but its N-terminal end 
may partially unfold as depicted by the wavy yellow line; in the second, it is stopped at the -clamp. The parallel dashed lines indicate 
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were also performed in the opposite direction, i.e., add-
ing LFN constructs to the trans solution and streptavidin 
to the cis. In this latter case, the voltage protocol was re-
versed, and the channels were blocked by negative volt-
ages and unblocked by positive voltages. Whereas with 
LFN added to the cis solution the unblocking kinetics at 
negative voltages are convoluted with the intrinsic gat-
ing kinetics of (PA63)7 channels, with LFN added to the 
trans solution the blocking kinetics at negative voltages 
are convoluted with the intrinsic gating kinetics of the 
channels. Nevertheless, it is clear that cis streptavidin 
can grab the N-terminal biotin (Figs. 11 and 12), thereby 
demonstrating that the channel can translocate LFN in 
either direction. Incidentally, this is the first demonstra-
tion that the (PA63)7 channel can, at least partially, trans-
locate LFN in the backward direction, but still, as in the 
forward direction, N-terminal end first. We tested the 
same LFN constructs in these trans-addition experiments 
as in the cis-addition experiments. Using biotins as the 
stopper, we could say that 28 residues are sufficient to 
reach the cis solution from the -clamp, but 20 residues 
are not (Fig. 11, inset). (We did not attempt to narrow 
the cutoff as finely in these LFN experiments as we did 
in the cis LFN experiments.) However, because 20 resi-
dues have an extended length of 72 Å, but the distance 
from the -clamp to the cis solutions is 50 Å (Fig. 1), 
this suggests that the biotin stopper is stopped some-
what short of the -clamp. Using YFP as the stopper, we 
see that 43 residues are sufficient to traverse the entire 
channel length from the trans side to the cis side, but 33 
residues are not (Fig. 12).
D I S C U S S I O N
Given the structure of the (PA63)7 channel, with its 15 Å–
wide, 100 Å–long stem (Fig. 1), it is obvious that for a 
globular protein to be translocated through it, the pro-
tein has to unfold. Certainly, tertiary structure must be 
lost, but it is not clear to what extent secondary struc-
ture is preserved, given that the stem is wide enough to 
accommodate an  helix with its side chains. In this pa-
per, we have addressed this question for LFN, the 263-
residue N-terminal fragment of LF, by determining how 
many of its residues are required to span the length of 
the channel. We did this by attaching a biotin at LFN’s   
N terminus, which is the end that first enters the chan-
nel on its way to being translocated, and a molecular 
stopper elsewhere in the molecule. After adding strep-
tavidin to the opposite side of the membrane (the trans 
side) from that to which LFN was added (the cis side), 
we then applied a voltage (50 mV) that would nor-
mally cause LFN to be translocated (were it not for the 
stopper). We established by its binding or not binding by 
streptavidin whether the N-terminal biotin had reached 
the trans solution. By varying the distance between the 
stopper and the N-terminal biotin, we thereby determined 
consequence of the fact that in addition to the LFN that 
is blocking the channel, there are one or two other LFNs 
bound to the cap, and these may sterically and/or elec-
trostatically interfere with the exiting of the blocking 
LFN from the channel at negative voltages.) To circum-
vent this problem, we used the above-mentioned double-
mutant (PA63)7 channel that does not bind LFN in the 
cap (Melnyk et al., 2006; Feld et al., 2010).
Two examples of the experiments with successive bio-
tins as the stopper are shown in Fig. 10. We see that 
trans streptavidin grabbed the N-terminal biotin with 
the biotin stoppers at positions 34 and 35, whereas it 
did not grab the N-terminal biotin with the biotin stop-
pers at positions 32 and 33. The results of these experi-
ments are summarized in the Fig. 10 inset, where we see 
that 31 residues are insufficient to traverse the stem of 
the channel, whereas 33 residues or more are sufficient. 
There is a sharp cutoff between 31 and 33 residues.
Reverse translocation
The experiments we have described of adding LFN con-
structs to the cis solution and streptavidin to the trans 
Figure 7.  The rate of capture by trans streptavidin of the biotin 
at residue 1 of (His)6-LFN constructs of various lengths, with YFP 
attached to the C terminus. These data come from experiments 
such as that depicted in Fig. 6 and are fit by single exponentials 
with the time constants indicated in the inset. The conductances 
are normalized to the value before the addition of LFN-YFP.   
The voltage protocol for all of these records was +50 mV for 5 s and 
40 mV for 15 s. Note that, as expected (see Results and Discus-
sion), the shorter the length of the construct, the longer the time 
constant. Most significantly, the biotin at residue 1 of LFN 1–23 is 
not captured by trans streptavidin, whereas that for LFN 1–33 is 
slowly captured. (The LFN 1–263 experiment was done on chan-
nels formed by the PA63 double mutant R178A/K214E.) The time 
on the abscissa is the cumulative time spent at positive and nega-
tive voltages.  Basilio et al. 351
to the trans solution. Because the -clamp is probably 
near the entrance to the stem of the mushroom-shaped 
(PA63)7 channels (Fig. 1), these 32 or 33 residues are 
spanning a distance of 120 Å (Fig. 1). As an  helix, 
with a rise of 1.5 Å per residue, these residues would 
only span a distance of 50 Å. On the other hand, as an 
extended chain of 3.6 Å per residue (Dickerson and 
Geis,  1969),  the  distance  spanned  by  these  residues 
would be 115–119 Å. We therefore can conclude that 
the first 33 residues of LFN traverse the -barrel stem of 
the channel in a largely extended configuration.
There is an unstated assumption in the above conclu-
sion, and indeed in all of our experiments. Namely, we 
have tacitly assumed that streptavidin is sampling a rep-
resentative state of LFN and not some rare, unusual 
state. Thus, a possible interpretation of our results 
might be that the LFN chain within the channel is pre-
dominantly  helical, that it only rarely adopts an ex-
tended configuration, and that it is this rare event that 
streptavidin captures. Although we certainly acknowl-
edge that the extended chain need not be rigidly fixed 
and that it could relax to a more ordered state (e.g., a 
part of it occasionally adopting an -helical structure), 
we  feel  that  our  data  are  consistent  with  the  chain 
spending most of the time extended. Consider Fig. 7, 
for example, and in particular compare the rate of bind-
ing of streptavidin to LFN 1–83 to that to LFN 1–43. The 
time constant for the former is 100 s and that for the 
latter is 200 s (see inset). (Although not directly relevant 
the minimum number of residues required to span the 
length of the channel. Note that the linker attaching   
biotin to the N terminus of LFN is very short because the 
biotin was attached through the reaction of the cysteine 
with MTS-biotin (see Fig. S1 B, inset). Thus, the cysteine 
(introduced by site-direct mutagenesis) at the N terminus 
of LFN must reach the trans solution in order for strep-
tavidin to bind to its attached biotin.
The number of residues spanning the channel
We used two different stoppers and LFN constructs to 
determine this minimum number of residues. One was 
YFP attached to the C terminus of truncated LFN con-
structs having a biotin at the N terminus. The other was 
whole LFN with one or two adjacent biotins attached at 
various distances from the biotin-containing N terminus. 
Both stoppers gave essentially the same minimum num-
ber of residues required to span the length of the chan-
nel. Namely, the YFP stopper gave a number slightly 
fewer than 33 residues (actually fewer than 36 residues 
including the linker) (Fig. 7), and the biotin stopper 
gave a number of 32 or 33 residues (Fig. 10). How are 
we to interpret these numbers, and what does their 
agreement imply?
Let us first turn to the biotin stopper result, whose in-
terpretation we feel is less ambiguous. It is fairly certain 
that the biotin stoppers stop at the -clamp (Fig. 9), 
and thus, 32 or 33 residues are the minimum number of 
residues required to span the distance from the -clamp 
Figure 8.  The rate of capture by trans streptavidin of biotin at residue 1 is a function of both the magnitude of the voltage pulse driving 
the LFN chain through the (PA63)7 channel (A) and the length of the pulse (B). The data in all of these records were obtained with the 
construct LFN 1–83 from experiments such as that depicted in Fig. 6. In A, the positive voltage pulse duration was 5 s; in B, the magnitude of 
the voltage pulse was +40 mV. The data points are fit by single exponentials. The conductances are normalized to the value before the 
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What do we make of the fact that we obtain the same 
result with the YFP stopper? The simplest interpretation 
is that it too stops at the -clamp (see Fig. 6, cartoon). 
Because YFP is cylindrical in shape with a length of 40 Å 
and a width of 30 Å (Rekas et al., 2002), this would 
mean that the vestibule leading to the -clamp is quite 
wide, at no place narrower than 30 Å. In the absence, at 
present, of structural data to contradict this, we are free 
to draw this conclusion. Another, less appealing inter-
pretation is that the agreement of the YFP stopper re-
sult with that of the biotin stopper is coincidental; that, 
in fact, YFP cannot enter the vestibule at all but can par-
tially unfold to extend a part of itself from the vestibule 
entrance to the -clamp (see Fig. 6, cartoon). Although 
unlikely, this possibility cannot be dismissed out of 
hand. The first 33 residues of LFN contain seven lysines, 
two arginines, and two histidines, which at pH 5.5 (the 
pH of our experiments) represent 10 positive charges. 
Assuming that aspartates and glutamates within these 33 
residues are protonated (Krantz et al., 2006; Finkelstein, 
2009), this means that there are 10 positive charges in 
the channel’s stem. Assuming that the 50 mV that we 
applied  in  our  experiments  drops  linearly  down  the 
100-Å stem, this translates into a force of 8 pN being 
to the argument that follows, the reader may note that 
because in these experiments the positive translocating 
voltage was applied for only 25% of the time [see figure 
legend], the actual time constants are 25 and 50 s, re-
spectively.) Now assume that the LFN within the channel 
is an  helix. LFN 1–83 would be about long enough 
(123 Å) to span the distance from the -clamp to the 
trans solution (120 Å) and thus always be exposed to 
the streptavidin in the trans solution. For LFN 1–43 with 
an -helical length of 63 Å to be grabbed by streptavidin 
at a rate only twofold slower than that for LFN 1–83, the 
entire LFN chain within the channel would have to 
spend approximately half of its time almost completely 
unfolded and half of its time  helical. We think this is 
most unlikely, and that a much more reasonable expla-
nation for the difference in time constants lies in the 
difference in the time of exposure to the trans solution 
of extended chains of 43 and 83 residues undergoing 
Brownian motion. That is, because of the Brownian mo-
tion of an extended chain, its N terminus will be drawn 
back into the channel where it is not exposed to the 
trans solution. The longer the chain, the less time its 
N terminus will be found in this retracted state, and hence 
the more time it will be exposed to the trans solution.
Figure 9.  Biotins introduced at most positions in LFN stop LFN translocation because the biotins cannot get past the -clamp. The data 
depicted come from experiments with the (His)6-LFN 1C/242C mutant that had been reacted with MTS-biotin to attach biotins at those 
sites. (A) Before the start of the record, the (PA63)7-induced conductance had leveled off, LFN had been added to the cis compartment 
to a concentration of 120 nM, the conductance had fallen to a fraction of the value before LFN addition, and LFN had been perfused out 
of the cis compartment. At t = 0, the voltage was stepped from +20 to +60 mV. We see that for the wild-type (PA63)7 channel, there was 
no translocation of LFN with a biotin attached at residue 242, whereas for the (PA63F427A)7 channel, where the phenylalanines of the 
-clamp have been mutated to alanines, translocation readily occurred, thus indicating that the biotin at residue 242 could not get past 
the -clamp. The dashed line is the zero current level. (B) The wild-type (PA63)7 channel record in A is a blow-up of the boxed segment 
of this record. As in Fig. 5 B, the point of the rest of the record is to show that the (PA63)7 channels are still present and have not simply 
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that we cannot exclude, a priori, the unfolding of YFP 
as a complicating factor in our experiments.
The results of the reverse translocation experiments, 
in which we added LFN to the trans side instead of to the 
cis side, nicely complement those results. In particular, 
the experiments with YFP as the stopper are especially 
revealing. Because YFP is much too large to enter the 
channel from the trans side, the distance measured in 
these experiments should give the entire length of the 
transmitted back to the YFP. This magnitude of force 
can cause partial unfolding of YFP (Perez-Jimenez et al., 
2006). It is by no means clear if the force being trans-
mitted to YFP in our experiments is acting at the same 
location as in the Perez-Jimenez et al. (2006) experi-
ments. Nor is it clear if the assumption that the applied 
voltage drops linearly in the stem (as opposed, for ex-
ample, to the idea that the entire voltage drop occurs 
across the -clamp) is valid. We are merely pointing out 
Figure 10.  Example of a (His)6-LFN construct (LFN 1C/34C/35C with these residues biotinylated) whose N terminus reached the trans 
solution, and a (His)6-LFN construct (LFN 1C/32C/33C with these residues biotinylated) whose N terminus did not reach the trans solu-
tion. Before the start of the records, (PA63)7 with the mutation R178/K214E was added to the cis compartment to a concentration of   
2 nM, with the voltage held at +20 mV, and after an appropriate level of current was reached, the cis compartment was perfused, which 
removed free (PA63)7 from solution and caused the current to level off. The relevant LFN cysteine mutant was then added to the cis solu-
tion to a concentration of 120 nM, and after the fall in conductance had leveled off, the voltage protocol of +55 mV for 12.5 s and 20 mV for 
37.5 s was begun. At the arrows, streptavidin was added to the trans compartment to a concentration of 1 µM. In both records, we see that 
before the addition of streptavidin, the level of unblocking was slowly decaying, having not yet reached a steady state. Most significantly, 
however, is that in the case of LFN 1C/34C/35C, this rate of decline increased dramatically upon addition of the trans streptavidin, 
indicating that the biotin at residue 1 had reached the trans solution and could be grabbed by streptavidin, whereas in the case of LFN 
1C/32C/33C, the rate of decline remained unchanged, indicating that the biotin at residue 1 could not reach the trans solution. The 
dashed line is the zero current level. The results of experiments such as these are summarized in the inset, where a blue dot indicates 
that the biotin at residue 1 did not reach the trans solution, and a red dot indicates that the biotin at residue 1 had reached the trans 
solution. Also given in the inset is the length in angstroms of the distance from residue 1 to the biotin stopper for an  helix ( Å) and 
for an extended chain (ext Å). The cartoon is similar to that in Fig. 6 (see legend); X aa is the number of amino acids from residue 1 
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this finding means that this region unfolds under the con-
ditions of our experiments and suggests that the (PA63)7 
channel actually unfolds the secondary structure of LFN as 
it is being translocated. Although this conclusion strictly 
applies only to the first 43 residues, there is no reason to 
believe that this is not equally true for any stretch of 
amino acids in the polypeptide chain.
Biotin as a stopper
All of our experiments depended on the fact that a biotin 
attached to the N terminus of LFN readily traverses the 
(PA63)7 channel. On the other hand, we showed that 
a biotin attached at most other positions in LFN was 
stopped at the -clamp and therefore could not tra-
verse the channel (Fig. 9). It was this fact that allowed 
us to use biotin (or two successive biotins) as a stopper. 
Why is the N-terminal biotin different from (almost) all 
other biotins? At first thought, one might attribute this 
difference as arising in some way from the fact that the 
N terminus is the first residue to pass through the   
-clamp. This, however, cannot be the case because all 
of  the  experiments  reported  here  were  done  with  a   
20-residue (His)6 tag attached to the N terminus of LFN. 
Thus, position 1 of LFN, its N terminus, is as much an 
channel 170 Å (Fig. 1). Given that the N-terminal bio-
tin of LFN 1–43 was grabbed by cis streptavidin, and re-
membering that there are three amino acids linking LFN 
to YFP, we come up with a distance of 162 Å (45 × 3.6 Å), 
which is close to 170 Å. This suggests that YFP does not 
partially unfold to any significant extent and somewhat 
obviates the concern raised in the preceding paragraph. 
This is supported by our finding that the N-terminal   
biotin of LFN 1–33, whose extended length is 126 Å (35 × 
3.6 Å), was not grabbed by cis streptavidin.
The conclusion that the first 33 residues of LFN trav-
erse the stem of the channel in an extended configura-
tion was derived from our experiments in which LFN was 
added to the cis side, where we found that these 33 resi-
dues were sufficient to span the distance from the   
-clamp to the trans solution. Because the structure of the 
first 27 residues of LFN is unresolved, it is possible that 
they are disordered in solution and simply remain so in 
their translocation through the channel. Our experiments 
in which LFN-YFP was added to the trans side, however, 
demonstrate that the first 43 residues of LFN (plus the 
three–amino acid linker) are sufficient to traverse the 
entire channel. Because the region from residue 28 to 43 
is  helical in the crystal structure (Pannifer et al., 2001), 
Figure  11.  Demonstration  that 
the (PA63)7 channel can translocate 
LFN (N-terminal end first) from the 
trans to the cis solution. This is essen-
tially the same type of experiment as 
the one depicted in Fig. 10, except 
in this case, the (His)6-LFN cysteine 
mutant  (LFN  1C/126C  with  these 
residues  biotinylated)  was  added 
to  the  trans  side  and  streptavidin 
was added to the cis side. After the 
(PA63)7-induced  conductance  had 
leveled  off,  the  LFN  cysteine  mu-
tant was added to the trans side to 
a concentration of 120 nM, and the 
voltage protocol of 50 mV for 10 s   
and +20 mV for 33 s was begun.   
At the arrow, streptavidin was added 
to the cis compartment to a concen-
tration of 1 µM. We see that before 
the addition of streptavidin, the level 
of  unblocking  was  declining,  hav-
ing not yet reached a steady-state.   
(Note  that  because  unblocking 
is  occurring  at  a  positive  voltage 
[+20 mV] rather than at a negative 
voltage,  it  is  not  obscured  by  the 
intrinsic (PA63)7 gating and in fact 
occurs very rapidly.) The rate of de-
cline,  however,  increased  dramati-
cally upon the addition of cis streptavidin, indicating that the biotin at residue 1 had reached the cis solution and could be grabbed 
by streptavidin. The dashed line is the zero current level. The results of experiments such as this are summarized in the inset, where a 
blue dot indicates that the biotin at residue 1 did not reach the cis solution, and a red dot indicates that it did. Also given in the inset 
is the length in angstroms of the distance from residue 1 to the biotin stopper for an  helix ( Å) and for an extended chain (ext Å). 
The cartoon is virtually identical to the one in Fig. 10, except in this instance, LFN has been added to the trans side and streptavidin was 
added to the cis side.  Basilio et al. 355
virtually all of the (PA63)7 channels ended up blocked 
(e.g., Fig. 6). In contrast to this, in those experiments in 
which biotins acted as the stopper, if trans streptavidin 
grabbed the N-terminal biotin, only a fraction of (PA63)7 
channels were ultimately blocked (e.g., Fig. 10). One 
possible explanation for this is that with the N-terminal 
biotin held by streptavidin, the biotin stoppers are 
dragged through the -clamp. Thus, a steady-state is 
reached between the rate at which streptavidin grabs 
the  N-terminal  biotin  of  LFN  and  thereby  keeps  the 
channels  blocked,  and  the  rate  at  which  LFNs  with 
grabbed N-terminal biotins are translocated and thereby 
unblock the channels. We tested this hypothesis in a 
translocation experiment, such as the one depicted in 
red in Fig. 9 A, by adding streptavidin to the trans solu-
tion, but we saw no significant increase in the rate of 
translocation of LFN (unpublished data). At this point, 
we have no explanation for why only a fraction of the 
channels was ultimately blocked.
“interior” position as any other. Another possibility is that 
because there are two glycines immediately following 
position 1, there is room for some water molecules to asso-
ciate with the biotin, and that somehow this facilitates 
passage of biotin through the -clamp. That this may be 
the explanation is indicated by our observation that LFN 
with a biotin attached to position 77, which is also immedi-
ately followed by two glycines, is translocated as readily 
as wild-type LFN (unpublished data). Interestingly, a simi-
lar phenomenon to that seen with biotin is also seen with 
SO3
; namely, LFN with an SO3
 introduced at either 
position 1 (the N terminus) or position 77 translocates 
as readily as wild-type LFN, but with an SO3
 at other po-
sitions it translocates very slowly (Basilio et al., 2009).
A puzzling difference between the YFP and biotin  
stopper experiments
In those experiments with YFP as the stopper, if trans strep-
tavidin grabbed the N-terminal biotin, then ultimately   
Figure 12.  Example of backward translocation of a (His)6-LFN construct (LFN 1–43 YFP with 1C biotinylated) whose N terminus reached 
the cis solution, and a (His)6-LFN construct (LFN 1–33 YFP with 1C biotinylated) whose N terminus did not reach the cis solution. This 
is essentially the same type of experiment as the one depicted in Fig. 6, except in this case, the relevant LFN-YFP mutant was added to 
the trans side and streptavidin was added to the cis side. After the (PA63)7-induced conductance had leveled off, the LFN-YFP mutant was 
added to the trans side to a concentration of 240 nM, and the voltage protocol of 80 mV for 6 s and +30 mV for 5.5 s was begun. At the 
arrow, streptavidin was added to the cis compartment to a concentration of 1 µM. We see that before the addition of streptavidin, the 
level of unblocking was declining, having not yet reached a steady state. Most significantly, however, is that in the case of LFN 1–43 YFP, 
this rate of decline increased dramatically upon the addition of the cis streptavidin, indicating that the biotin at residue 1 had reached 
the cis solution and could be grabbed by streptavidin, whereas in the case of LFN 1–33 YFP, the rate of decline remained unchanged, 
indicating that the biotin at residue 1 could not reach the cis solution. The dashed line is the zero current level. The cartoon is virtually 
identical to that in Fig. 11, except that here YFP, instead of biotins, is the stopper.356 Trapping a permeating LFN in the anthrax channel
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